Prognostic value of a high on-clopidogrel treatment platelet reactivity in bivalirudin versus abciximab treated non-ST-segment elevation myocardial infarction patients: ISAR-REACT 4 (Intracoronary stenting and antithrombotic regimen: Rapid early action for coronary treatment-4) platelet substudy

Journal of the American College of Cardiology

Volumn 60, Issue 5, 2012, Pages 369-377

  Sibbing, Dirk ^a   Bernlochner, Isabell ^a   Schulz, Stefanie ^a   Massberg, Steffen ^a   Schömig, Albert ^a   Mehilli, Julinda ^a   Kastrati, Adnan ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

abciximab; bivalirudin; clopidogrel

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; CLOPIDOGREL; HEPARIN; HIRULOG;

AGED; ANTICOAGULANT THERAPY; ARTICLE; BLOOD CLOTTING PARAMETERS; BLOOD SAMPLING; CARDIOVASCULAR PARAMETERS; COHORT ANALYSIS; CONTINUOUS INFUSION; DEATH; DRUG EFFICACY; FEMALE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HIGH ON CLOPIDOGREL TREATMENT PLATELET REACTIVITY; HUMAN; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; THROMBOCYTE FUNCTION; THROMBOSIS; TREATMENT DURATION; TREATMENT RESPONSE;

AGED; ANGIOPLASTY, BALLOON, CORONARY; ANTIBODIES, MONOCLONAL; ANTICOAGULANTS; ANTITHROMBINS; COHORT STUDIES; COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; ELECTROCARDIOGRAPHY; FEMALE; HEPARIN; HIRUDINS; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PEPTIDE FRAGMENTS; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PLATELET FUNCTION TESTS; PROGNOSIS; RECOMBINANT PROTEINS; SIGNAL PROCESSING, COMPUTER-ASSISTED; STENTS; SURVIVAL ANALYSIS; TICLOPIDINE;

EID: 84864283890     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2012.02.044     Document Type: Article

References (29)

1. P.A. Gurbel, K.P. Bliden, B.L. Hiatt, C.M. O'Connor Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity Circulation 107 2003 2908 2913 (Pubitemid 36736631)
2. W. Hochholzer, D. Trenk, H.P. Bestehorn Impact of the degree of peri-interventional platelet inhibition after loading with clopidogrel on early clinical outcome of elective coronary stent placement J Am Coll Cardiol 48 2006 1742 1750 (Pubitemid 44648629)
3. D. Sibbing, S. Braun, T. Morath Platelet reactivity after clopidogrel treatment assessed with point-of-care analysis and early drug-eluting stent thrombosis J Am Coll Cardiol 53 2009 849 856
4. L. Bonello, U.S. Tantry, R. Marcucci Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate J Am Coll Cardiol 56 2010 919 933
5. P.A. Gurbel, K.P. Bliden, K. Guyer Platelet reactivity in patients and recurrent events post-stenting: results of the PREPARE POST-STENTING study J Am Coll Cardiol 46 2005 1820 1826 (Pubitemid 41579802)
6. D. Aradi, A. Komocsi, A. Vorobcsuk Prognostic significance of high on-clopidogrel platelet reactivity after percutaneous coronary intervention: systematic review and meta-analysis Am Heart J 160 2010 543 551
7. M.J. Price, P.B. Berger, P.S. Teirstein Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial JAMA 305 2011 1097 1105
8. D. Trenk, G.W. Stone, M. Gawaz et al. A randomized trial of prasugrel versus clopidogrel in patients with high platelet reactivity on clopidogrel after elective percutaneous coronary intervention with implantation of drug-eluting stents: results of the TRIGGER-PCI (Testing Platelet Reactivity in Patients Undergoing Elective Stent Placement on Clopidogrel to Guide Alternative Therapy With Prasugrel) study J Am Coll Cardiol 59 2012 2159 2164
9. G.W. Stone ADAPT-DES: a large-scale, prospective, multicenter registry examining the relationship of platelet responsiveness to stent thrombosis after DES implantation Transcatheter Cardiovascular Therapeutics 2011 San Francisco, CA November 9, 2011
10. C.W. Hamm, J.P. Bassand, S. Agewall ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the Task Force for the Management of Acute Coronary Syndromes (ACS) in Patients Presenting Without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC) Eur Heart J 32 2011 2999 3054
11. A. Kastrati, F.J. Neumann, J. Mehilli Bivalirudin versus unfractionated heparin during percutaneous coronary intervention N Engl J Med 359 2008 688 696
12. A. Kastrati, J. Mehilli, H. Schuhlen A clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrel N Engl J Med 350 2004 232 238 (Pubitemid 38071801)
13. A. Kastrati, J. Mehilli, F.J. Neumann Abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention after clopidogrel pretreatment: the ISAR-REACT 2 randomized trial JAMA 295 2006 1531 1538
14. G.W. Stone, B. Witzenbichler, G. Guagliumi Bivalirudin during primary PCI in acute myocardial infarction N Engl J Med 358 2008 2218 2230 (Pubitemid 351724451)
15. G.W. Stone, B.T. McLaurin, D.A. Cox Bivalirudin for patients with acute coronary syndromes N Engl J Med 355 2006 2203 2216 (Pubitemid 44791162)
16. A. Kastrati, F.J. Neumann, S. Schulz Abciximab and heparin versus bivalirudin for non-ST-elevation myocardial infarction N Engl J Med 365 2011 1980 1989
17. Z. Xiao, P. Theroux Platelet activation with unfractionated heparin at therapeutic concentrations and comparisons with a low-molecular-weight heparin and with a direct thrombin inhibitor Circulation 97 1998 251 256 (Pubitemid 28067310)
18. D. Sibbing, S. Braun, S. Jawansky Assessment of ADP-induced platelet aggregation with light transmission aggregometry and multiple electrode platelet aggregometry before and after clopidogrel treatment Thromb Haemost 99 2008 121 126
19. D. Sibbing, S.R. Steinhubl, S. Schulz, A. Schomig, A. Kastrati Platelet aggregation and its association with stent thrombosis and bleeding in clopidogrel-treated patients: initial evidence of a therapeutic window J Am Coll Cardiol 56 2010 317 318
20. M. Valgimigli, G. Campo, N. de Cesare Intensifying platelet inhibition with tirofiban in poor responders to aspirin, clopidogrel, or both agents undergoing elective coronary intervention: results from the double-blind, prospective, randomized Tailoring Treatment with Tirofiban in Patients Showing Resistance to Aspirin and/or Resistance to Clopidogrel study Circulation 119 2009 3215 3222
21. T. Cuisset, C. Frere, J. Quilici Glycoprotein IIb/IIIa inhibitors improve outcome after coronary stenting in clopidogrel nonresponders: a prospective, randomized study J Am Coll Cardiol Intv 1 2008 649 653
22. O. Lairez, J. Roncalli, D. Carrie Relationship between time of day, day of the week and in-hospital mortality in patients undergoing emergency percutaneous coronary intervention Arch Cardiovasc Dis 102 2009 811 820
23. S.D. Wiviott, E. Braunwald, C.H. McCabe Prasugrel versus clopidogrel in patients with acute coronary syndromes N Engl J Med 357 2007 2001 2015 (Pubitemid 350106708)
24. L. Wallentin, R.C. Becker, A. Budaj Ticagrelor versus clopidogrel in patients with acute coronary syndromes N Engl J Med 361 2009 1045 1057
25. G. Davi, C. Patrono Platelet activation and atherothrombosis N Engl J Med 357 2007 2482 2494
26. J.M. Siller-Matula, K. Haberl, K. Prillinger, S. Panzer, I. Lang, B. Jilma The effect of antiplatelet drugs clopidogrel and aspirin is less immediately after stent implantation Thromb Res 123 2009 874 880
27. T. Geisler, M. Kapp, K. Gohring-Frischholz Residual platelet activity is increased in clopidogrel- and ASA-treated patients with coronary stenting for acute coronary syndromes compared with stable coronary artery disease Heart 94 2008 743 747 (Pubitemid 351744692)
28. G. Dangas, R. Mehran, G. Guagliumi Role of clopidogrel loading dose in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty: results from the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial J Am Coll Cardiol 54 2009 1438 1446
29. L. Bonello, M. Pansieri, J. Mancini High on-treatment platelet reactivity after prasugrel loading dose and cardiovascular events after percutaneous coronary intervention in acute coronary syndromes J Am Coll Cardiol 58 2011 467 473